CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash Flows from Operating Activities:
Consolidated Net income	$ 9,329	$ 12,463
Adjustments to reconcile consolidated net income to net cash provided by operating activities:
Depreciation and amortization	3,536	3,546
Net change in operating right-of-use assets and lease liabilities	15	(472)
Provision for credit losses	2,608	1,674
Deferred tax expense	878	3,003
Gain on sale of equipment – related party		(577)
Changes in operating assets and liabilities, net:
Accounts, medical and management fee receivable(s)	(7,140)	(8,835)
Notes receivable		55
Notes receivable – related party	(39)
Inventories	8	(365)
Prepaid expenses and other current assets	(1,093)	243
Other assets	6	(28)
Accounts payable	(631)	97
Other current liabilities	(549)	(1,095)
Financing lease liabilities	(153)	(163)
Customer deposits	111	(49)
Other liabilities	159	(1)
Net cash provided by operating activities	7,045	9,496
Cash Flows from Investing Activities:
Purchases of property and equipment	(3,145)	(375)
Proceeds(Purchase) from short term investments	13	(102)
Cost of patents	(25)	(24)
Net cash used in investing activities	(3,157)	(501)
Cash Flows from Financing Activities:
Repayment of borrowings and capital lease obligations	(114)	(32)
Sale of noncontrolling interest	132
Purchase of treasury stock	(1,806)	(1,885)
Distributions to noncontrolling interests	(4,184)	(4,376)
Net cash used in financing activities	(5,972)	(6,293)
Net (Decrease) Increase in Cash and Cash Equivalents	(2,084)	2,702
Cash and Cash Equivalents - Beginning of Period	56,341	51,280
Cash and Cash Equivalents - End of Period	$ 54,257	$ 53,982